News & announcements.
Milestones, awards, publications, partnerships and company updates from miRoncol Health.
Progress you can trace.
The archive connects published research, scientific recognition, leadership appointments, partnerships and company-building milestones.
Cancer blood test prototype could one day be a game-changer
Media coverage: imagine if a simple blood test could check for early signs of several common cancers at the same time, a look at miRoncol’s approach.
Read update November 7, 2025CEO Victoria Xu Honoured at the 2025 City of Ottawa Immigrant Entrepreneur Awards
miRoncol’s CEO and co-founder Victoria Xu was named one of five recipients of the 2025 City of Ottawa Immigrant Entrepreneur Awards.
Read update November 5, 2025SaaS North, Meet Us at the miRoncol Booth
From the investor seat to the founder’s booth: CEO Victoria Xu returned to SaaS North, this time exhibiting miRoncol’s technology.
Read update October 7, 2025miRoncol Presents on the Elevate Festival Main Stage
CEO Victoria Xu took the main stage on opening night at Elevate Festival, the premier gathering for Canada’s innovation community.
Read update September 11, 2025ArchAngel Open House & Waterloo Tech Week
miRoncol attended the Archangel Network of Funds Open House during Waterloo Tech Week 2025.
Read update April 17, 2025miRoncol Hosts a Booth at OCI DiscoveryX 2025
miRoncol hosted a booth at OCI DiscoveryX in Toronto, connecting with fellow advocates for a future of accessible early detection.
Read update April 3, 2025Selected to Present at Venture Summit West
miRoncol presented at Venture Summit West in Mountain View, CA, a premier event connecting high-growth startups with investors.
Read update February 7, 2025OBIO Investment Summit Presentation
miRoncol presented at the 2025 OBIO Investment Summit, a premier event for Canadian life sciences, healthcare, and innovation.
Read update January 8, 2025miRoncol Appoints Dr. Christopher Gallagher as Chief Medical Officer
Dr. Christopher M. Gallagher, a medical oncologist with 20+ years of experience, joined miRoncol as Chief Medical Officer.
Read update November 20, 2024CHEO Bear’s Den Pitch
miRoncol Health shone at the CHEO Bear’s Den 2024 innovation pitch competition.
Read update October 17, 2024miRoncol at the 2024 MedTech Conference, and Its Nobel Prize Connection
The miRoncol team attended the MedTech 2024 Conference in Toronto, a global platform for medtech innovators and executives.
Read update October 16, 2024miRoncol Develops Multi-Cancer Early Detection Blood Test
miRoncol announced the completion of proof-of-concept studies for a multi-cancer early detection blood test.
Read update October 15, 2024miRoncol Unveils Breakthrough Blood Test to Detect 12+ Early-Stage Cancers
miRoncol completed proof-of-concept studies for a blood test designed to detect signals associated with multiple early-stage cancers.
Read update September 5, 2024Selected to Present at Venture Summit New York
The miRoncol team was selected to present at the New York Venture Summit, hosted by youngStartup Ventures.
Read update August 2, 2024miRoncol Wins 2024 ASCO Breakthrough Abstract Award
miRoncol received a 2024 Breakthrough Merit and Abstract Award for its machine-learning-based noninvasive diagnostic work.
Read update April 2024miRoncol Establishes Its Business Advisory Board
miRoncol established its Business Advisory Board to provide strategic guidance as the company advances its mission.
Read update April 2024miRoncol Appoints Victoria Xu as Chief Executive Officer
miRoncol appointed Victoria Xu as Chief Executive Officer, effective April 2024.
Read update October 15, 2023Poster Accepted at ESMO Congress 2023
miRoncol’s poster was accepted by the European Society for Medical Oncology (ESMO) Congress 2023, a major global oncology event.
Read update October 2023miRoncol Establishes Its Scientific Advisory Board
miRoncol established its Scientific Advisory Board of internationally recognized experts to guide the science.
Read update April 14, 2022Poster Presented at AACR Annual Meeting 2022
miRoncol presented its development and validation work at the 2022 American Association for Cancer Research (AACR) Annual Meeting.
Read update March 11, 2022World’s First Published miRNA Multi-Cancer Early Detection Model
The world’s first published miRNA-based multi-cancer early detection model was detailed in the journal Cancers.
Read update September 9, 2021Oral Presentation at the World Conference on Lung Cancer 2021
miRoncol’s featured presentation unveiled early work on a blood-based test for early lung cancer detection.
Read updateSee the company behind the milestones.
Meet the leadership team and understand how scientific, clinical and company-building experience comes together around one microRNA intelligence platform.